Novartis has spent considerable time and energy building its presence in the IgA nephropathy (IgAN) disease area, and now | ...
May 14, 2008 — The blocking of epidermal growth-factor receptors (EGFR) to treat non-small-cell lung cancer is becoming increasingly common, but there is considerable debate about when to initiate ...
Stories by SWNS on MSN
Mum’s rib pain put down to 60-hour work weeks turned out to be lung cancer
A mum whose rib pain and dizziness were put down to the physical demands of working 60-hour-weeks was diagnosed with lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback